中国临床药学杂志2024，Vol.33Issue(1)：18-22,5.DOI:10.19577/j.1007-4406.2024.01.003
部分医疗机构《β内酰胺类抗菌药物皮肤试验指导原则(2021年版)》的实施情况调查
Investigation and analysis of the current implementation of the"guidelines for skin testing of β-lactam antibacterial drugs(2021 edition)"by some medical institutions
何苗 1张海霞 1赵昕 1王晓玲2
作者信息
- 1. 湖南省儿童医院药学部,长沙 410007
- 2. 首都医科大学附属北京儿童医院药学部,北京 100045
- 折叠
摘要
Abstract
AIM To investigate the implementation status of the"guidelines for skin testing of β-lactam antibacterial drugs(2021 edition)"in some medical institutions.METHODS A questionnaire via Questionnaire Star was used to assess the management of cephalosporin skin tests and the level of understanding among medical personnel of the"guidelines for skin testing of β-lactam antibacterial drugs(2021 Edition)"in 56 medical institutions.RESULTS A total of 407 valid questionnaires were collected achieving a response rate of 100％.Following the issuance of the guidelines,the proportion of medical institutions that ceased performing cephalosporin skin tests increased from 17.86％to 58.93％,while 32.14％of medical institutions had not discontinued skin tests for cephalosporin drugs.Medical personnel had a high level of discernment regarding allergic history(97.79％),and a high accuracy rate in recording positive skin test results(96.07％).Furthermore,the majority of medical institutions(96.43％)provided training for the management of severe allergic reactions.However,there was a relatively low understanding of indications for cephalosporin skin tests,the significance of skin tests,the implications of positive/negative predictive values,and the medication for rescuing anaphylactic shock.CONCLUSION The implementation status of the guidelines is suboptimal.There is a need to improve the level of understanding of the guidelines among medical personnel.关键词
β内酰胺类药物/头孢菌素类药物/抗菌药物/皮肤试验Key words
β-lactams/cephalosporins/antimicrobial drug/skin test引用本文复制引用
何苗,张海霞,赵昕,王晓玲..部分医疗机构《β内酰胺类抗菌药物皮肤试验指导原则(2021年版)》的实施情况调查[J].中国临床药学杂志,2024,33(1):18-22,5.
